Comparative Analysis of Lactate to Albumin Ratio versus CRP to Albumin Ratio in Mechanically Ventilated Patients
Abstract:
Mechanically
ventilated patients in intensive care units (ICUs) often suffer from severe,
life-threatening conditions that need close monitoring and precise therapeutic
interventions. Biomarkers are crucial in investigating the prognosis, guiding
treatment decisions, and predicting outcomes in these critically ill patients.
Among these biomarkers, the Lactate to Albumin Ratio (LAR) and the C-Reactive
Protein to Albumin Ratio (CAR) have emerged as significant predictors of
morbidity and mortality. The present study focuses on conducting a comparative
analysis of LAR versus CAR in mechanically ventilated patients. An
observational study was conducted on 50 mechanically ventilated patients, aged
between 25 to 80 years, in the intensive care unit (ICU). The serum biomarkers
like Lactate, CRP and albumin levels, were measured upon admission to the
intensive care unit (ICU). Additionally, the other outcomes were assessed such
as ICU mortality and length of stay. The findings revealed that the mean age of
the patient was 55.64±16.52
years. Both the lactate-to-albumin ratio (0.70) and the CRP-to-albumin
ratio (0.69) were significantly associated with ICU mortality. The p values of
these two parameters were 0.03 and 0.04 respectively in lactate to albumin
ratio and CRP to albumin ratio. The lactate-to-albumin ratio was more strongly
correlated with markers of metabolic stress and tissue hypoxia, while the CRP-to-albumin
ratio was a stronger predictor of inflammation severity. Both ratios provide
valuable prognostic insights for mechanically ventilated patients. However, the
lactate to albumin ratio is more indicative of metabolic stress and CRP to
albumin ratio reflects inflammatory status, with lactate to albumin ratio being
a more reliable indicator of prognosis in mechanically ventilated patients.
References:
[1]. Marini, J. J., Gattinoni, L., 2020, Management of COVID-19
Respiratory Distress. Journal of the
American Medical Association, 323(22), 2329-2330. 10.1001/jama.2020.6825.
[2]. Demoule, A., Decavele, M., Antonelli, M., 2024, Dyspnoea
in acutely ill mechanically ventilated adult patients: an ERS/ESICM
statement. Intensive Care Medicine, 50, 159–180. 10.1007/s00134-023-07246-x.
[3]. Phua, J., Weng, L., Ling, L., Egi,
M., Lim, C. M., 2020, Asian Critical Care Clinical Trials Group. Intensive care
management of coronavirus disease 2019 (COVID-19): challenges and
recommendations. Lancet Respiratory Medicine,
8(5), 506-517. 10.1016/S2213-2600(20)30161-2.
[4]. Guttormson, J. L., Khan, B., Brodsky,
M. B., Chlan, L. L., 2023, Symptom Assessment for Mechanically Ventilated
Patients: Principles and Priorities: An Official American Thoracic Society
Workshop Report. Annals of the American
Thoracic Society, 20(4), 491-498. 10.1513/AnnalsATS.202301-023ST.
[5]. Bodaghi, A., Fattahi, N., Ramazani,
A., 2023, Biomarkers: Promising and valuable tools towards diagnosis, prognosis
and treatment of Covid-19 and other diseases. Heliyon, 9(2): e13323. 10.1016/j.heliyon. 2023.e13323.
[6]. Das, S., Dey, MK., Devireddy, R.,
Gartia MR., 2024, Biomarkers in cancer detection, diagnosis, and Prognosis. Sensors, 24(1):37. 10.3390/s24010037.
[7]. Zhang, N., Liu, Y., Yang, C., Li,
X., 2024, Review of the predictive value of biomarkers in Sepsis Mortality. Emergency Medicine International, 5, 2715606.
10.1155/2024/2715606.
[8]. Jang, J. H., Hong, S., Ryu, J. A.,
2022, Prognostic Value of C-Reactive Protein and Albumin in Neurocritically Ill
Patients with Acute Stroke. Journal of Clinical
Medicine, 11(17), 5067. 10.3390/jcm11175067.
[9]. Ryoo, S. M., Kim, W. Y., 2018,
Clinical applications of lactate testing in patients with sepsis and septic
shock. Journal of Emergency and Critical
Care Medicine, 2:14. 10.21037/jeccm.2018.01.13.
[10]. Kabra, Ruchita; Acharya, Sourya; Kumar, Sunil., 2020, Serum
Lactate Levels in Critically Ill Patients: An Early Marker to be Targeted. Journal of the Scientific Society, 49(3),
246-250. 10.4103/jss.jss_113_22.
[11]. Sauer, C. M., Gomez, J., Botella, M. R., 2021, Understanding
critically ill sepsis patients with normal serum lactate levels: results from
U.S. and European ICU cohorts. Scientific Reports, 11, 20076. 10.1038/s41598-021-99581-6.
[12]. Plebani, M., 2023, Why C-reactive
protein is one of the most requested tests in clinical laboratories? Clinical Chemistry and Laboratory Medicine,
61(9), 1540-1545. 10.1515/cclm-2023-0086.
[13]. Heymann, M., Schorer, R., Putzu, A.,
2023, The effect of cytosorb on inflammatory markers in critically ill
patients: A systematic review and meta-analysis of randomized controlled trials.
Critical Care Medicine, 51(12), 1659-1673.
10.1097/CCM.0000000000006007.
[14]. Belinskaia, D. A., Voronina, P. A.,
Goncharov, N. V., 2021, Integrative role of albumin: Evolutionary, biochemical
and pathophysiological aspects. Journal
of Evolutionary Biochemistry and Physiology, 57(6), 1419-1448.
10.1134/S002209302106020X.
[15]. Wiedermann, C. J., 2021,
Hypoalbuminemia as surrogate and culprit of infections. International Journal of Molecular Sciences, 22(9), 4496.
10.3390/ijms22094496.
[16]. Zhou, X., Fu, S., Wu, Y., Guo, Z.,
Dian, W., Sun, H., Liao, Y., 2023, C-reactive protein-to-albumin ratio as a
biomarker in patients with sepsis: A novel LASSO-COX based prognostic nomogram.
Scientific Reports, 13(1), 15309.
10.1038/s41598-023-42601-4.
[17]. Fagarasan, G., Seicean, R.,
Bintintan, V., Fagarasan, V., Caziuc, A., Andras, D., 2024, The value of
preoperative C-Reactive protein to albumin ratio as a prognostic biomarker in
colon cancer patients. Medicina, 60(7),
1054. 10.3390/medicina60071054.
[18]. Bajwah, S., Oluyase, A. O., Yi D, W.,
Evans, C. J., Grande, G., Higginson, I. J., 2020, The effectiveness and
cost-effectiveness of hospital-based specialist palliative care for adults with
advanced illness and their caregivers. Cochrane
Database of Systematic Reviews, 9(9), CD012780.
10.1002/14651858.CD012780.pub2.
[19]. Lee, S. I., Huh, J. W., Hong, S. B.,
Koh, Y., Lim, C. M, 2024, Age distribution and clinical results of critically Ill
patients above 65-Year-Old in an aging society: A retrospective cohort study. Tuberculosis and Respiratory Diseases, 87(3),
338-348. 10.4046/trd.2023.0155.
[20]. Singhal, S., Singh, S., Dewangan, G.
C., Dey, S., Banerjee, J., 2023, The prevalence of frailty and its relationship
with sociodemographic factors, regional healthcare disparities, and healthcare
utilization in the aging population across India. Aging Medecine, 6(3), 212-221. 10.1002/agm2.12263.
[21]. Lat, T. I., McGraw, M. K., White, H.
D., 2021, Gender differences in critical illness and critical care Research. Clinics in Chest Medicine, 42(3), 543-555.
10.1016/j.ccm.2021.04.012.
[22]. Li, X., Yang, Y., Zhang, B., Lin, X.,
Fu, X., Yu, T., 2022, Lactate metabolism in human health and disease. Signal Transduction and Targeted Therapy,
7(1), 305. 10.1038/s41392-022-01206-5.
[23]. Erdogan, M., Findikli, H. A., 2022,
Prognostic value of the lactate/albumin ratio for predicting mortality in
patients with pneumosepsis in intensive care units. Medicine (Baltimore), 101(4), e28748. 10.1097/MD.000000000002874.
[24]. Sproston, N. R., Ashworth, J. J., 2018,
Role of C-Reactive protein at sites of inflammation and infection. Frontiers Immunology, 9, 754. 10.3389/fimmu.2018.00754.
[25]. Tharavath, V., Rao, P. B., Nayak, S.,
Panda, A., Bandyopadhyay, D., Pati, S., 2023, Preoperative C-reactive protein -
Albumin ratio as a predictor of requirement for postoperative mechanical
ventilation after non-cardiac surgery under general anaesthesia: A prospective
observational study (HICARV). Indian Journal
Anesthesia, 67(3):262-268. 10.4103/ija.ija_295_22.